Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Qtrilmet approved in the EU for the treatment of type-2 diabetes
-
US FDA accepts regulatory submission for selumetinib in neurofibromatosis type 1 and grants Priority Review
-
Anifrolumab demonstrated superiority across multiple efficacy endpoints in patients with systemic lupus erythematosus in Phase III TULIP 2 trial
-
Roxadustat Phase III programme pooled analyses showed positive efficacy and no increased cardiovascular risk in patients with anaemia from chronic kidney disease
-
Roxadustat significantly increased haemoglobin levels for chronic kidney disease patients with anaemia in Phase III OLYMPUS and ROCKIES trials
-
Calquence data to show improved progression-free survival in Phase III front-line chronic lymphocytic leukaemia trial at ASH 2019 Annual Meeting
-
AstraZeneca announces three large-scale initiatives in China to advance global medicine research and development
-
AstraZeneca to present pivotal roxadustat Phase III data at the American Society of Nephrology Kidney Week 2019
-
AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia
-
Imfinzi and Imfinzi plus tremelimumab delayed disease progression in Phase III POSEIDON trial for 1st-line treatment of Stage IV non-small cell lung cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
